InvestSMART

ResMed Inc. (ASX: RMD) - Announcements

Current share price for RMD : $29.790 0.46 (1.52%)+

ASX company news and announcements for ResMed Inc. (RMD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All ResMed Inc. (RMD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than ResMed Inc. (RMD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for ResMed Inc. (RMD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$17,695 Share Registry Change of Address 27 May 2024 8:19AM $31.800 $29.790 fallen by 6.32%
$17,695 Update - Dividend/Distribution - RMD 10 May 2024 12:25PM $32.590 $29.790 fallen by 8.59%
$17,695 Statement of CDIs on issue - RMD 3 May 2024 11:01AM $33.020 $29.790 fallen by 9.78%
$17,695 Form 10-Q for the Quarter ended March 31, 2024 29 Apr 2024 8:08AM $31.500 $29.790 fallen by 5.43%
$17,695 Dividend/Distribution - RMD 26 Apr 2024 8:23AM $28.740 $29.790 risen by 3.65%
$17,695 ResMed Announces Results for the Third Quarter of FY2024 26 Apr 2024 8:23AM $28.740 $29.790 risen by 3.65%
$17,695 ResMed to Report Third Quarter Fiscal 2024 Results 5 Apr 2024 8:27AM $28.540 $29.790 risen by 4.38%
$17,695 Statement of CDIs on issue - RMD 4 Apr 2024 12:24PM $28.415 $29.790 risen by 4.84%
$17,695 Statement of CDIs on issue - RMD 4 Mar 2024 11:26AM $27.020 $29.790 risen by 10.25%
$17,695 Update - Dividend/Distribution - RMD 9 Feb 2024 12:57PM $28.510 $29.790 risen by 4.49%
$17,695 Statement of CDIs on issue - RMD 5 Feb 2024 11:02AM $29.400 $29.790 risen by 1.33%
$17,695 Form 10-Q for the Quarter ended December 31, 2023 29 Jan 2024 8:18AM $28.450 $29.790 risen by 4.71%
$17,695 Dividend/Distribution - RMD 25 Jan 2024 8:37AM $26.750 $29.790 risen by 11.36%
$17,695 ResMed Announces Results for the Second Quarter of FY2024 25 Jan 2024 8:36AM $26.750 $29.790 risen by 11.36%
$17,695 Statement of CDIs on issue - RMD 5 Jan 2024 12:43PM $24.975 $29.790 risen by 19.28%
$17,695 ResMed to Report Second Quarter Fiscal 2024 Results 4 Jan 2024 8:26AM $25.160 $29.790 risen by 18.40%
$17,695 Statement of CDIs on issue - RMD 5 Dec 2023 12:57PM $24.720 $29.790 risen by 20.51%
$17,695 Form 8K 21 Nov 2023 9:23AM $22.830 $29.790 risen by 30.49%
$17,695 ResMed Inc. Amended and Restated Bylaws 21 Nov 2023 9:17AM $22.830 $29.790 risen by 30.49%
$17,695 Update - Dividend/Distribution - RMD 10 Nov 2023 10:57AM $22.550 $29.790 risen by 32.11%
$17,695 ResMed Adopts New Operating Model 10 Nov 2023 10:07AM $22.980 $29.790 risen by 29.63%
$17,695 Statement of CDIs on issue - RMD 3 Nov 2023 10:30AM $23.535 $29.790 risen by 26.58%
$17,695 FORM 10Q for Qtr ended September, 2023 30 Oct 2023 3:38PM $21.820 $29.790 risen by 36.53%
$17,695 Dividend/Distribution - RMD 27 Oct 2023 8:11AM $22.460 $29.790 risen by 32.64%
$17,695 ResMed Announces Results for the First Quarter of FY2024 27 Oct 2023 8:11AM $22.460 $29.790 risen by 32.64%

276 - 300 of 703 results

Page 12 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.